A new transthyretin variant (Glu61Gly) associated with cardiomyopathy

Amyloid

Volumn 14, Issue 1, 2007, Pages 65-71

  Rosenzweig, Michael ^a   Skinner, Martha ^a   Prokaeva, Tatiana ^a   Théberge, Roger ^a   Costello, Catherine ^a   Drachman, Brian M ^b   Connors, Lawreen H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiomyopathy; Familial amyloidosis; Genetic mutation; Transthyretin

Indexed keywords

ADENINE; AMYLOID; GLUTAMIC ACID; GLYCINE; GUANINE; PREALBUMIN;

AGED; AMYLOIDOSIS; ARTICLE; CARDIOMYOPATHY; CARPAL TUNNEL SYNDROME; CASE REPORT; CLINICAL FEATURE; CODON; DNA SEQUENCE; EXON; FAMILIAL AMYLOIDOSIS; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HEART MUSCLE BIOPSY; HETEROZYGOSITY; HUMAN; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SERODIAGNOSIS; WILD TYPE;

EID: 33947648959     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120601116625     Document Type: Article

References (14)

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
2. Benson M, Uemichi T. Review: Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996;3:44-56.
3. Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K. Structure of the human prealbumin gene. J Biol Chem 1985;260:12224-12227.
4. Lashuel HA, Lai Z, Kelly JW. Characterization of the transthyretin acid denaturation pathways by analytical ultra-centrifugation: Implications for wild type, V30M, and L55P amyloid fibril formation. Biochemistry 1998;37:17851-17864.
5. Schormann N, Murrell J, Benson M. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: New model for amyloid fibril formation. Amyloid: Int J Exp Clin Invest 1998;5:175-187.
6. Connors LH, Lim A, Prokaeva T, Roskens V, Costello C. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Folding Dis 2003;10:160-194.
7. Ng B, Connors L, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure. A comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425-1429.
8. Connors LH, Ericsson T, Skare J, Jones LA, Lewis WD, Skinner M. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta 1998;1407:185-192.
9. Lim A, Prokaeva I, McComb ME, O'Connor PB, Théberge R, Connors LH, Skinner M, Costello CE. Characterization of transthyretin varients in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem 2002;74:741-751.
10. Shiomi K, Nakazato M, Matsukura S, Ohnishi A, Hatanaka H, Tsuzi S, Murai Y, Kojima M, Kangawa K, Matsuo H. A basic transthyretin variant (GLU61 to LYS) causes familial amyloidotic polyneuropathy: Protein and DNA sequencing and PCR-induced mutation restriction analysis. Biochem Biophys Res Comm 1993;194:1090-1096.
11. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80.
12. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
13. Miroy G, Lai Z, Lashuel H, Peterson S, Strang C, Kelly J. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci USA 1996;93:15051-15056.
14. Adamski-Werner S, Palaninathan S, Sacchettini J, Kelly J. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J Med Chem 2004;47:355-374.